atherosclerotic disease

POISE-3 Trial Summary: Tranexamic Acid in Noncardiac Surgery

2022 POISE-3 TRIAL МІ Tranexamic Acid in Patients Undergoing Noncardiac Surgery International, randomized, controlled trial Objective: In patients undergoing noncardiac surgery who are at risk for bleeding and CV events, does tranexamic acid lowers incidence of major bleeding when compared … Read More